Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 11/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.40 |
| ▸ | STAMBP | O95630 | 1/20 | 0.40 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | F7 | P08709 | 1/20 | 0.35 |
| ▸ | F3 | P13726 | 1/20 | 0.35 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.35 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.35 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.35 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.35 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.35 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7720516 | 0.80 | NNMT (0.41) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| SCHEMBL29050819 | 0.80 | GABRP (0.41) | NNMTSMN1; SMN2PSMD14LMNAKDM4E | |
| SCHEMBL28617172 | 0.78 | LMNA (0.44) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| SCHEMBL27372639 | 0.78 | PARP1 (0.51) | NNMTSMN1; SMN2SIRT3MKNK1MKNK2 | |
| SCHEMBL2219734 | 0.78 | NNMT (0.46) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| Hydrochloric Acid SCHEMBL28641941 | 0.76 | NNMT (0.44) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| SCHEMBL30478243 | 0.75 | NNMT (0.41) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| SCHEMBL28285907 | 0.75 | NNMT (0.41) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| SCHEMBL1503085 | 0.75 | NNMT (0.40) | NNMTSMN1; SMN2PSMD14STAMBPCOPS5 | |
| SCHEMBL31327199 | 0.73 | NNMT (0.50) | NNMTSMN1; SMN2HPGDSKDM4ESIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8702854-B2 | Azaphthalocyanines and their use in ink-jet printing | FUJIFILM CORPORATION (JP) | 2014-04-22 | — | — | US | disclosed |
| EP-2376577-B1 | AZAPHTHALOCYANINES AND THEIR USE IN INK-JET PRINTING | FUJIFILM IMAGING COLORANTS LTD (GB) | 2012-12-26 | — | — | EP | disclosed |
| CN-102264842-A | Azaphthalocyanines and their use in ink-jet printing | — | 2011-11-30 | — | — | CN | disclosed |
| EP-2376577-A2 | AZAPHTHALOCYANINES AND THEIR USE IN INK-JET PRINTING | FUJIFILM Imaging Colorants Limited (GB) | 2011-10-19 | — | — | EP | disclosed |
| US-20110234687-A1 | Azaphthalocyanines and Their Use in Ink-Jet Printing | Fujifilm Imaging Colorants, Limited (GB) | 2011-09-29 | — | — | US | disclosed |
| WO-2010070313-A2 | AZAPHTHALOCYANINES AND THEIR USE IN INK-JET PRINTING | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2010-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110234687-A1 | Azaphthalocyanines and Their Use in Ink-Jet Printing | JMJD1C, PCBP1, ZYX | NNMT 639/4885SMN1; SMN2 2718/4885PSMD14 2294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.